scispace - formally typeset
Search or ask a question

Phosphorylation of Tie2 by Ang1? 


Best insight from top research papers

Activation of the Tie2 receptor by Ang1 leads to phosphorylation of Tie2 . Ang1-induced Tie2 dimerization occurs via the formation of an intermolecular β-sheet between the membrane-proximal Fibronectin type III domains of Tie2 . The phosphorylation of Tie2 is essential for its activation and downstream signaling .

Answers from top 3 papers

More filters
Papers (3)Insight
Ang1 induces Tie2 phosphorylation by promoting Tie2 dimerization through the formation of an intermolecular β-sheet between the Fn3 domains of Tie2.
Yes, the new soluble ANG1 mimetic, Hepta-ANG1, induces Tie2 phosphorylation in cultured cells and in the lung following intravenous injection of mice.
When Ang1 binds to Tie2, it leads to the auto-phosphorylation of Tie2, which promotes anti-apoptotic activity in vascular endothelial cells.

Related Questions

How does studied phosphorylation?5 answersProtein phosphorylation is studied through various methods and approaches. One approach involves the purification and manipulation of phosphoproteins, using computational and biochemical techniques to analyze their structure and function. Another strategy combines fluorescence resonance energy transfer (FRET) with a small molecule ATP analogue to study protein phosphorylation in living cells. Phosphorylation can also be examined through PAGE electrophoresis and tandem mass spectrometry (MS/MS) to identify specific phosphorylation sites. Additionally, a novel method based on the phosphorylation-dependent electrophoretic mobility shift (PDEMS) has been developed to detect protein phosphorylation, allowing for the measurement of the ratio of protein phosphorylation in cells. These different approaches provide insights into the mechanisms and functional implications of protein phosphorylation in various cellular processes.
AMPK phosphorylation promotes ACC phosphorylation?is?5 answersAMPK phosphorylation does not appear to be essential for the phosphorylation of ACC. In a study by Zordoky et al., a double knock-in mouse model was generated to prevent AMPK-dependent inhibitory phosphorylation of ACC. Despite the inability of AMPK to regulate ACC activity, the hearts from these mice displayed normal basal AMPK activation and cardiac function, indicating that AMPK-dependent inactivation of ACC is not necessary for the control of myocardial fatty acid oxidation (FAO) and cardiac function. Another study by Janovska et al. found that leptin stimulated the phosphorylation of AMPK and ACC in lean animals, but this effect was absent in obese animals, suggesting that the effect of leptin on AMPK and ACC phosphorylation is muscle fiber type dependent and fails in diet-induced obesity. Therefore, while AMPK phosphorylation may play a role in the regulation of ACC activity, it is not essential for ACC phosphorylation.
What are the mechanisms by which ANG2 elevations lead to HHT pathologies?3 answersElevated levels of ANG2 have been implicated in various pathologies. In sepsis-associated lung injury, ANG2 disrupts endothelial barrier function, leading to vascular leak and impaired oxygenation. In chronic heart failure, ANG2 is associated with sympathoexcitation and blunted arterial baroreflex function. ANG2 also plays a role in cardiac hypertrophy, with the activation of AT1 receptors mediating physiological hypertrophy and the reduction of AT2 receptors and Mas receptors contributing to pathological hypertrophy. Additionally, ANG2 is involved in abnormal collagen deposition and altered cardiac function in hypertrophy and heart failure. In hypertension, elevated circulating levels of ANG2 can disrupt the blood-brain barrier, allowing access of ANG2 to critical sympathoexcitatory brain centers, exacerbating sympatho-humoral activation. These mechanisms collectively contribute to the pathologies associated with ANG2 elevations.
How FoxO1 regulates Ang2 expression?5 answersFoxO1 regulates Ang2 expression through the Akt/FKHR pathway, as demonstrated in the study by Daly et al.. They found that Ang-1, a regulator of vascular development, inhibits FKHR (FOXO1) through Akt activation, thereby modulating gene expression. FKHR regulates genes associated with vascular destabilization and remodeling, including Ang-2, an Ang-1 antagonist. Ang-1 inhibits FKHR-mediated changes in gene expression, including the expression of Ang-2. This study provides insight into the molecular mechanisms underlying Ang-1 function and its role in regulating endothelial cell survival and blood vessel stability.
What are the effects of phosphorylation of Tie2 on Ang1?5 answersPhosphorylation of Tie2 has been shown to have effects on Ang1 signaling. In one study, it was found that mutation in the Tie2 tyrosine 1106 residue directed endothelial progenitor cells (EPCs) towards a mature endothelial phenotype, which was associated with increased phosphorylation of the active site (tyrosine 992). Another study demonstrated that both Ang1 and Ang2 binding to Tie2 increased Tie1-Tie2 interactions in a β1 integrin-dependent manner, and Tie1 was essential for the agonist activity of Ang1. These findings suggest that phosphorylation of Tie2 may play a role in mediating the effects of Ang1 on endothelial cells and EPCs. However, further research is needed to fully understand the specific mechanisms and consequences of Tie2 phosphorylation in the context of Ang1 signaling.
What is the effect of VEGF on phosphorylation of Tie2?4 answersVEGF has been shown to regulate the phosphorylation of Tie2. It induces proteolytic cleavage and shedding of Tie2 via a PI3K/Akt-dependent pathway. VEGF treatment leads to both constitutive and inducible Tie2 shedding, which is mediated by PI3K/Akt and p38 MAPK. Overexpression of the lipid phosphatase PTEN blocks Tie2 shedding, while overexpression of dominant negative PTEN or constitutively active Akt enhances Tie2 shedding. The shedding of Tie2 by VEGF inhibits angiopoietin-Tie2 signaling, resulting in the inhibition of vascular stabilization and promotion of angiogenesis and vascular remodeling.

See what other people are reading

How is MIF involved in angiogenesis of prostate cancer?
5 answers
Macrophage migration inhibitory factor (MIF) plays a crucial role in angiogenesis in prostate cancer. MIF, a proinflammatory cytokine, is released by stromal and tumor cells, promoting malignant growth and metastasis by stimulating tumor cell proliferation, inhibiting apoptotic death, facilitating extracellular matrix invasion, and enhancing angiogenesis. Studies suggest that MIF, acting through its receptor CD74, is a pro-tumorigenic factor in genitourinary cancers, including prostate cancer, by promoting angiogenesis and other cancer hallmarks. Additionally, MIF inhibition in preclinical models reduces angiogenesis and tumor aggressiveness by downregulating key signaling pathways, such as ERK and AKT. Understanding the role of MIF in angiogenesis is crucial for developing novel therapeutic strategies targeting this pathway in prostate cancer.
What is the role of food consumption in EGCG supplementation?
5 answers
Food consumption significantly impacts the bioavailability and effects of EGCG supplementation. Studies show that taking EGCG without food leads to better systemic absorption, with significantly higher plasma levels compared to ingestion with food or in food matrices. High-dose EGCG supplements, commonly consumed during pregnancy, can adversely affect neurodevelopment by disrupting neural progenitor cell development in vitro, emphasizing the need for caution in such scenarios. Additionally, a combination of phytochemicals, including EGCG, in dietary supplements has shown positive effects on aging biomarkers, inflammation, and telomere length, highlighting the potential health benefits of combined phytochemical administration. Moreover, EGCG has been found to inhibit angiogenesis, a crucial process for follicle development, which raises concerns about the reproductive consequences of EGCG feeding supplementation.
Which OD is used to sort e. coli on a FACS using eGFP?
5 answers
The optical density (OD) commonly used to sort E. coli on a Fluorescence-Activated Cell Sorter (FACS) utilizing enhanced green fluorescence protein (eGFP) is not explicitly mentioned in the provided contexts. However, the studies discuss the optimization of FACS-based immunoassays using E. coli with autodisplayed Z-domains expressing eGFP in the cytosol to enhance sensitivity and eliminate artifactual signals. Additionally, a novel FACS method is developed to screen for cells with increased peptide production, demonstrating the power of FACS in metabolic engineering. Furthermore, a study describes the isolation of fluorescent bacteria using a benchtop FACSCalibur-sort flow cytometer, emphasizing the importance of high purity in single-cell sorting processes. Another method involves high-throughput screening of protein variants by encapsulating single cells into agarose beads for clonal growth and subsequent FACS sorting.
How to increase androgen receptors?
5 answers
To increase androgen receptors (AR), various approaches can be considered based on the findings from different research contexts. Firstly, treatment with type I interferons (IFNs) like IFN-alpha can lead to increased levels of AR protein in normal human prostate stromal and epithelial cells. Additionally, regulating the polyglutamine length in the AR gene can impact AR function, with longer polyglutamine tracts affecting specific DNA binding and transcriptional activation. Moreover, studies suggest that variations in trinucleotide polymorphisms within the AR gene can influence AR expression levels, potentially impacting male infertility. Furthermore, growth factors like IGF-I, KGF, and EGF have been shown to stimulate AR-mediated transcription in the absence of androgens, indicating a potential mechanism to modulate AR activity. These insights collectively suggest that utilizing IFNs, regulating polyglutamine length, and considering growth factor stimulation could be strategies to increase androgen receptors.
How does estrogen affect the expression of lipoxygenase in different tissues?
4 answers
Estrogen exerts varying effects on lipoxygenase (LO) expression in different tissues. In rat brain homogenates and hippocampal cells, estrogen hormones like estrone and 17beta-estradiol reduce lipid peroxidation (LPO) levels, indicating a protective role against oxidative damage. Conversely, in lenses from female rabbits, estradiol activates the lipoxygenase pathway, leading to the formation of specific LO products, which can be prevented by progestin treatment. Additionally, in breast cancer cells, epidermal growth factor (EGF) stimulation increases 12-LO activity and expression, potentially promoting cancer cell growth. These findings highlight the tissue-specific and context-dependent regulation of lipoxygenase expression by estrogen, with implications for oxidative stress, inflammatory responses, and cancer progression.
How is the influence of physical exercise training on HIF activation?
5 answers
Physical exercise training has a significant impact on hypoxia-inducible factor (HIF) activation. Studies show that exercise stimulates and activates the HIF-1 pathway, including vascular endothelial growth factor (VEGF) signaling, leading to angiogenesis and increased capillary growth. Endurance training under hypoxic conditions enhances the activity of the HIF pathway in skeletal muscle, improving aspects of muscle oxygen transport and metabolism. Additionally, increased levels of reactive oxygen species (ROS) due to exercise induce the expression of PGC-1α, which regulates mitochondrial biogenesis and increases VEGF expression, promoting angiogenesis independently of HIF-1α. Activation of the HIF pathway, even without exposure to atmospheric hypoxia, enhances the effects of running training, indicating the importance of combining training with HIF activation for maximal training benefits.
What is the influence of Centella asiatica on the kidneys?
4 answers
Centella asiatica has a significant impact on kidney health. Studies have shown that Centella asiatica can inhibit renal tissue cytokines and extracellular matrix production, thereby potentially inhibiting renal fibrosis. Additionally, Centella asiatica extract, specifically the C3 fraction, has been found to reduce antioxidant gene expression and induce anti-proliferative effects in kidney cells, suggesting potential toxicity at high concentrations. Furthermore, research on unilateral ureteral obstruction (UUO) mouse models revealed that Centella asiatica treatment dose-dependently ameliorates mesenchymal transition and inflammation in kidney fibrosis, leading to reduced tubular injury and interstitial fibrosis. In diabetic rat models, Centella asiatica treatment at the early stage of diabetes mellitus has shown to ameliorate glomerulosclerosis and vascular injury by increasing antioxidant enzymes, thus protecting against diabetic nephropathy.
What is the influence of Centella asiatica on the crystal formation in the urine?
4 answers
Centella asiatica has shown beneficial effects on various aspects of health, but its influence on crystal formation in urine is not directly addressed in the provided contexts. However, Centella asiatica has been extensively studied for its antioxidant, anti-inflammatory, and renal protective properties. These properties may indirectly impact crystal formation in urine by potentially reducing oxidative stress and inflammation in the kidneys, which are factors that can contribute to crystal formation. Studies have demonstrated that Centella asiatica can ameliorate kidney injury, inhibit renal tissue cytokines, and reduce fibrosis. These effects suggest that Centella asiatica may have a positive influence on kidney health, which could potentially extend to reducing crystal formation in the urine. Further research specifically focusing on crystal formation is warranted to provide a conclusive answer.
What are the specific antibodies of vascular endothelial cells?
5 answers
The specific antibodies for vascular endothelial cells include those targeting PECAM1 and CDH5 extracellular matrix domains. Additionally, there are antibodies against VEGF, such as VEGF-specific human antibodies for diagnosis, disease classification, treatment, and prognostic evaluation. Furthermore, antibodies against pro-angiogenic forms of VEGF have been developed, capable of neutralizing these isoforms without affecting anti-angiogenic ones, with applications in therapy and diagnosis. Moreover, VEGF-B polypeptides and corresponding antibodies are utilized to promote mitosis and proliferation of vascular endothelial cells, stimulating angiogenesis and serving diagnostic purposes. Lastly, monoclonal antibodies targeting human VEGF or VEGF-related proteins are developed for therapeutic use in diseases characterized by excessive vascular endothelial cell proliferation, as well as for diagnostic purposes.
What is the currennt therapeutic approaches targeting inhibitory immune cells within the TME ?
5 answers
Current therapeutic approaches targeting inhibitory immune cells within the tumor microenvironment (TME) focus on reversing the suppression exerted by these cells to enhance antitumor immune responses. Strategies include utilizing PD-1 and PD-L1 inhibitors in non-small cell lung cancer (NSCLC), understanding suppressive mechanisms of TME-resident inhibitory immune cells to develop therapies that improve NK cell functions, inhibiting VEGF and TGF-β pathways to normalize the TME and enhance sensitivity to immunotherapy like PD-1/PD-L1 inhibitors, and targeting molecules/pathways critical for multiple cell types within the TME, such as BCL-2 family proteins, STAT3, and epigenetic regulators, to achieve long-term therapeutic responses. These approaches aim to create a more immune-supportive TME, leading to improved clinical outcomes in patients with solid tumors.
What to do if dmba do not casuing mammary gland cancer in mice of old age?
5 answers
If DMBA does not induce mammary gland cancer in older mice, several factors may be considered. Firstly, the age of the mice plays a crucial role in tumorigenesis, as DMBA exposure during the peripubertal period (4-10 weeks of age) is more effective in inducing mammary tumors. Additionally, the influence of the total burden of DMBA given and the number of doses administered can impact tumor onset. Furthermore, the interaction between DMBA-induced mammary carcinogenesis and the phosphatidylinositol 3-kinase/protein kinase B/cyclin-dependent kinase 1 pathway may provide insights into the lack of cancer development in older mice. Moreover, attenuating TGFB signaling in macrophages has been shown to decrease mammary tumor incidence, suggesting a potential role of macrophages in DMBA-induced tumorigenesis. Ultimately, understanding these factors can help elucidate the mechanisms behind the lack of DMBA-induced mammary gland cancer in older mice.